Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001062993-25-001088

Options or other derivatives

  • Chief Medical Officer acquired 162,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Goncalves Joana Chief Medical Officer 2025-01-22 Grant or award · Employee Stock Option (right to buy) +162,500 162,500 D
Loading xslF345X05/form4.xml…